Stay updated on Palovarotene for MO: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Palovarotene for MO: Efficacy & Safety Clinical Trial page.

Latest updates to the Palovarotene for MO: Efficacy & Safety Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedNo additions or deletions were observed on the Study Details page for NCT03442985. The page content remains focused on study overview, design, eligibility, and outcome measures.SummaryDifference0.1%

- Check17 days agoChange DetectedAdded multiple location entries (California, District of Columbia, Ontario, Osaka, North Holland, etc.) and removed several existing locations, with a new revision tag v3.3.3.SummaryDifference2%

- Check24 days agoChange DetectedNo significant changes detected on the Study Details page; the content and layout remain focused on palovarotene MO trial details, eligibility criteria, interventions, and locations.SummaryDifference0.1%

- Check39 days agoChange Detected- Revision label updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check46 days agoChange DetectedThe Publications section text was updated to indicate publications are automatically filled from PubMed and may not all be about the study. The revision tag was updated from v3.2.0 to v3.3.1.SummaryDifference0.2%

- Check53 days agoChange DetectedThe government funding notice about possible delays and operating status was removed; study details and other content remain unchanged.SummaryDifference0.4%

Stay in the know with updates to Palovarotene for MO: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Palovarotene for MO: Efficacy & Safety Clinical Trial page.